Monday, 31 August 2026European Markets

PIERRE VACANCES Stock Is 34% Up In The Last 21 Sessions

Loading stream...

(vianews) - shares of pierre vacances (cac 40: vac.pa) rose by a staggering 34.86% in 21 sessions from €1.27 to €1.71 at 16:07 est on wednesday, after two consecutive sessions in a row of gains. cac 40 is jumping 0.95% to €7,282.40, after two consecutive sessions in a row of gains.

pierre vacances's last close was €1.78, 75.95% below its 52-week high of €7.40.

about pierre vacances

pierre et vacances sa, through its subsidiaries, engages in the holiday accommodation and holiday property investment business in europe and internationally. the company operates through two segments, property development and tourism. it engages in the property development and; operation of residences and villages marketed under the pierre & vacances, center parcs, maeva, and aparthotels adagio brands. the company also offers online holiday rental and rental management services through its platform maeva.com. it operates approximately 283 sites and 44,500 apartments. the company was founded in 1967 and is headquartered in paris, france. pierre et vacances sa is a subsidiary of société d'investissement touristique et immobilier.

earnings per share

as for profitability, pierre vacances has a trailing twelve months eps of €9.93.

pe ratio

pierre vacances has a trailing twelve months price to earnings ratio of 0.17. meaning, the purchaser of the share is investing €0.17 for every euro of annual earnings.

more news about pierre vacances (vac.pa).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Hawkish Fed Signals at Jackson Hole Pressure Rate-Sensitive Assets
Kevin Warsh's hawkish inflation remarks at Jackson Hole, alongside a steady drumbeat of Federal Reserve testimony from Powell, Barr, Bowman and other officials on supervision, regulation and monetary policy, signal continued vigilance against inflation rather than an imminent easing cycle. Rate-sensitive and precious-metals-linked names such as SSR Mining sold off the same day, consistent with markets repricing for a firmer-for-longer policy stance.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,979
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,979 facts checked against source5,261 source documents archived
Query this data → isubstrate.com